Clinical trial
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
NCT03554265 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 6, 2018
- Completion date
- October 4, 2023
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.